Xifaxan (rifaximin) / Norgine, Alfa Wassermann, Lupin, ASKA Pharma, Bausch Health  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health
NCT05098028: Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Completed
2a
44
Canada, US, RoW
Low Dose Rifaximin ER, Low Dose Rifaximin DER, High Dose Rifaximin ER, High Dose Rifaximin DER, Placebo
Bausch Health Americas, Inc.
Sickle Cell Disease
09/23
09/23
NCT04118699: Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Active, not recruiting
2
12
Japan
Rifaximin oral tablet, L-105, Placebo oral tablet
Yokohama City University, ASKA Pharmaceutical Co., Ltd.
Chronic Intestinal Pseudo-obstruction
11/21
01/22
NCT05502913: Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Recruiting
2
80
RoW
Antibiotics, Rifaximin, FMT (Fecal Microbiota Transplantation)
Soroka University Medical Center, Biotax Labs LTD, Israel Cancer Association
Metastatic Lung Cancer
06/25
06/28
EFFACE-PD, NCT05204641: Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease

Active, not recruiting
1/2
60
Europe
Fecal Microbiota Transfer provided by Human Biome Institute, Pretreatment with rifaximin 3x 400 mg PO for 7 days, Assessment of levodopa/benserazide 100+25 mg tablet absorption before and 90 days after intervention: 20,40, 60, 90, 120, 150, 180 and 240 min since intervention- Area under the curve (AUC), Cmax, Assessment in clinical scales
Medical University of Warsaw, Human Biome Institute S.A.
Parkinson Disease
10/23
12/24
MICRO-PD, NCT03575195: Microbiota Intervention to Change the Response of Parkinson's Disease

Suspended
1/2
86
US
Rifaximin, Placebo
University of California, San Francisco, Nova Southeastern University, Gateway Institute for Brain Research
Parkinson Disease
06/25
06/25

Download Options